Boardroom Media (CFO News)
At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Canada based CFO’ operating in the Medical space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Neil Klompas
Chief Financial Officer & EVP Business Operations of Zymeworks
Mr. Klompas is Zymeworks’ Chief Financial Officer, and brings over 20 years of healthcare and biotechnology experience to Zymeworks’ management team. Additionally, in conjunction with the CEO, he manages Zymeworks’ corporate growth initiatives including corporate alliances, licensing and partnerships. Prior to joining Zymeworks he worked with KPMG LLP in Canada and the US, most recently with KPMG’s Pharmaceuticals, Biotechnology and Medical Device M&A Transaction Services practice in Princeton NJ, where he advised on numerous transactions including mergers, acquisitions, divestitures and strategic alliances. Prior to that, Mr. Klompas worked with KPMG’s Canadian Biotechnology and Pharmaceuticals practice in the fields of assurance, valuations and taxation. Mr. Klompas is a Chartered Accountant and is a member of the institute of CA’s of British Columbia.
Follow Neil Klompas:
About Zymeworks: Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Michael Singer
Chief Financial Officer of Clementia Pharmaceuticals
Michael Singer is the chief financial officer of [Clementia Pharmaceuticals](https://www.crunchbase.com/organization/clementia-pharmaceuticals), a biopharmaceutical company focused on innovative therapies for people living with rare diseases. He was previously the CFO of Bedrocan Cannabis. Singer holds a bachelor’s degree from Concordia University.
Follow Michael Singer:
About Clementia Pharmaceuticals: Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders.
Vasco Larcina. CPA
Chief Financial Officer of Lumira Ventures
Contributing over 20 years of senior financial management and audit experience, Vasco is a key member of senior management working closely with our investment team, external auditors and other finance professionals and acting as the primary point of contact for our limited partners. Having worked through the re-organization of the company and the disposition of the retail segment of the business, Vasco now focuses on the growth of the institutional fund management business, the streamlining of finance and legal operations and external reporting to our limited partners. Responsible for the financial management of Lumira Ventures and the investment funds it manages, Vasco oversees financial and legal operations, ensuring that the appropriate controls are in place to manage the activities of Lumira Ventures and its managed funds through the strategic evaluation, development and implementation of financial policies, systems and procedures developed in consideration of external reporting, risk and governance as well as regulatory and tax compliance. Prior to joining Lumira Ventures, Vasco worked as an external auditor with KPMG and has gained internal audit and operational audit experience with a regulated public utility where he provided the internal control input for a major customer information system development project.
Follow Vasco Larcina. CPA:
About Lumira Ventures: Canada’s leading health care & life sciences venture capital firm with a 30-year reputation building companies across North America.
Bill Mantzoutsos
Chief Financial Officer & Director of JADE Healthcare Group Inc.
Co-Founder of JADE Healthcare Group.
Follow Bill Mantzoutsos:
About JADE Healthcare Group Inc.: Intelligent Cloud Computed Health Monitoring
Miroslav Beganovic
Chief Financial Officer of Cannvas MedTech Inc
Miroslav Beganovicis CFO at Cannvas Medtech.
Follow Miroslav Beganovic:
About Cannvas MedTech Inc: Cannvas MedTech is a technology company within the cannabis space.
Patrick Montpetit
Partner and Chief Financial Officer of NuChem Sciences
Patrick Montpetit has over fifteen years of experience in senior financial management positions. He is a chartered accountant, specializing in corporate finance and has extensive experience in the life sciences and biopharmaceutical industries. Prior to joining Immunotec, Mr. Montpetit served as Vice-President, Finance and Chief Financial Officer of Bioniche Life Sciences Inc. and Director of Finance, Administration, Commercial Agreements and Alliances with DSM Biologics Inc. His professional experience includes serving as Chairman of the Quebec Biotechnology Association and Director of the Montreal InVivo organization.
Follow Patrick Montpetit:
About NuChem Sciences: NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal.
Michael English
Chief Financial Officer of Alternate Health
Mike English has over 30 years’ experience working in diverse industries including data security and encryption software, telecommunications, and heavy industrial electric motors and controls. Ten of those years were with a leading software as a service (SAAS) public encryption company where he served as controller and CFO. Under Mike’s leadership, the company drastically improved earnings and cash flow while reducing the company’s risk profile and improving compliance. They achieved best in class public company audit committee ISS governance ratings. As a Vice President of Finance and Controller in the telecommunications and heavy industrial electric motors and controls industries, Mike managed large groups including director level direct reports in multi-locations, both domestic and international (US, Canada, UK, Germany, Italy and Israel). In addition to accounting and reporting responsibilities, a major part of his role included implementing and integrating enterprise wide software (SAP) across several manufacturing divisions. Over a career that spans auditing, controllership, financial systems and senior executive financial management, Mike’s experience reaches across technical accounting, financial reporting and disclosure controls, risk avoidance, multi-location, SEC reporting, public company corporate governance, equity compensation, manufacturing cost accounting and includes HR and benefits, IT, facilities management and strategy. Mike earned a BA in English with a concentration in business from John Carroll University and an MS in Accountancy from DePaul University. He is a CPA and is a member of the Ohio Society of CPA’s.
Follow Michael English:
About Alternate Health: Alternate Health is a healthcare investment company specializing in the software development for the healthcare industry.
Benoit Lorrain
Co-Founder & CFO of Genia Photonics
Benoit Lorrain is Co-Founder & CFO at Genia Photonics.
Follow Benoit Lorrain:
About Genia Photonics: Genia Photonics develops picosecond fiber laser systems for molecular spectroscope systems.
Simon Buckett
CFO of HealthTech Connex
Mr. Buckett brings with him over twelve years of finance and project management experience working for private and publicly listed companies in the UK, US, and Canada. Mr. Buckett began his career with KPMG in London and then in Vancouver as Senior Auditor, later joining Ernst & Young as an audit department Manager. Most recently he was Vice President of Finance at Wurldtech Security Technologies, Inc. His responsibilities have included internal control and governance policy, the implementation of Sarbanes-Oxley in a number of SEC registrants, and managing the reporting requirements of a range of private and public companies.
Follow Simon Buckett:
About HealthTech Connex: HealthTech Connex focuses on technology-based innovations for health improvements and outcomes.
Yacine Amrani
CFO of Glycovax Pharma
Follow Yacine Amrani:
About Glycovax Pharma, Massfilter, Travoom: Glycovax Pharma focuses on developing nano-medicines to treat cancers and other diseases.
Don Wright
CFO of Clarius Mobile Health
Follow Don Wright:
About Clarius Mobile Health: Clarius is developing a novel medical imaging ecosystem.
Nate Tchaplia
Chief Financial Officer of Dental Corp
Nate Tchaplia is the Chief Financial Officer at Dental Corp.
Follow Nate Tchaplia:
About Dental Corp: Revolutionize the business of dentistry
David Prue
Chief Financial Officer of Oxy Bump Corporation
David Prue brings crucial start-up specific knowledge and experience, having worked with companies to and through their public offerings. His public company directorship, capital raising, and start-up business development skills are a valuable contribution to the Oxy Bump team. David’s expertise in financial management, administration and strategic/financial planning are rounded out by an operational understanding of inventory management, operations planning and execution, and corporate administration. As an environmental proponent, David has actively sought out and worked with early stage companies with a global consciousness and positive social impact. His prior experiences include companies with offerings of diversion and organic recycling as well as alternative energy solutions.
Follow David Prue:
About Oxy Bump Corporation: Oxy Bump’s distinctive line of products are the only oxygen-infused nasal/throat sprays in mass market.
Akmal Jameel
Chief Financial Officer of Fusion Genomics Corporation
Follow Akmal Jameel:
About Fusion Genomics Corporation, SensoDrive Technology: Fusion Genomics develops highly sensitive and massively multiplex DNA/RNA sequencing based diagnostics for infectious diseases.
George Dorin
Chief Financial Officer & Corporate Secretary of Pyng Medical
Mr. Dorin has 30 years of broad-based financial experience, including 15 years as a Corporate Director or CFO for several private and public companies. He holds undergraduate degrees in Science and Accounting from the University of BC, a Masters Degree in Finance from the London School of Economics, and the Diploma FCSI (Fellow of the Canadian Securities Institute). A Chartered Accountant, he was also granted a CF (Corporate Finance) specialist designation from the CICA in 2008. Prior to his work in industry, he worked in the financial services sector with Ernst & Whinney (now KPMG), Price Waterhouse, Royal Bank of Canada, and with Pemberton Securities (now RBC Dominion Securities). In 2007 and 2008 he was a Senior VP Corporate Finance at Wolrige Mahon, a BC-based CA Firm. Most recently, he has been providing corporate finance, senior financial management and corporate director (including audit committee chairman) services to several industrial public companies through this own company CANUS Capital Corporation.
Follow George Dorin:
About Pyng Medical: Pyng Medical develops trauma and resuscitation products for the health care industry.
Nelson Isabel
Chief Financial Officer & Senior Vice President, Finance of Highland Therapeutics
Follow Nelson Isabel:
About Highland Therapeutics: Highland Therapeutics is a specialty pharmaceutical company that uses technologies to optimize the delivery of previously approved drugs.
Branko Jankovic
VP & CFO of Ceapro
Follow Branko Jankovic:
About Ceapro: Ceapro is into developing functionally active ingredients derived from oats and renewable plant resources for healthcare and cosmetic needs.
Bruce Colwill
CFO of InMed Pharmaceuticals
Bruce Colwill is the Chief Financial Officer at InMed Pharmaceuticals.
Follow Bruce Colwill:
About InMed Pharmaceuticals: InMed Pharmaceuticals is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates.
Scott Wilson
CFO of Evasc Neurovascular Enterprises
Follow Scott Wilson:
About Evasc Neurovascular Enterprises: Evasc Neurovascular is a privately held medical device company
Scott Wilson
CFO of Evasc Neurovascular Enterprises
Follow Scott Wilson:
About Evasc Neurovascular Enterprises: Evasc Neurovascular is a privately held medical device company
Bill Adams
Chief Financial Officer of NervGen Pharma
Follow Bill Adams:
About NervGen Pharma: NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.
Tak Wing Law
CFO of The Jenex Corporation
Tak Wing Law has over 20 years of experiences as a finance professional and business executive and has worked with various companies and professional firms in Canada, China and Hong Kong including Price Waterhouse, Law Society of Hong Kong etc. He is now the Director of Finance of Kingsdale Shareholder Services Inc., a transfer agent registered with US Securities Exchange Commission. Mr. Law has been involved in processing the transactions including merger and acquisition and plan of arrangement of publicly-traded companies. He also handles the corporate reporting and compliance including auditing, financial reporting, taxation and EDGAR filing. Before coming to Canada, he founded T W Law & Co. in 1996 specializing in corporate restructuring and bankruptcy and had been appointed as trustee of bankruptcy by the Court of First Instance of the High Court of Hong Kong. He has a Master of Arts from University of Oklahoma, U.S and Postgraduate Diplomas from Hong Kong Polytechnic University. Mr. Law is a Certified General Accountant, Chartered Accountant in England and Wales, a Certified Public Accountant in Hong Kong. He is also an associate member of Chartered Secretary Canada.
Follow Tak Wing Law:
About The Jenex Corporation: Jenex is a progressive medical technology company focused on providing consumers with quality dermatological products.
